Ignite Creation Date:
2024-05-06 @ 7:04 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05882357
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2023-05-19
Brief Title:
Evaluation of ElexacaftorTezacaftorIvacaftor ELXTEZIVA in Cystic Fibrosis CF Participants 12 to Less Than 24 Months of Age
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-19
First Submit QC Date:
May 19 2023
Study First Post Date:
2023-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-14
Last Update Post Date:
2024-06-17
Last Update Post Date Type:
ACTUAL